Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neuro XPF is a consumer health and wellness company specializing in hemp-derived CBD products tailored for athletes and active individuals. Founded in 2017 by former NFL All-Pro offensive lineman Kyle Turley, the company was born out of Turley's personal journey using CBD to manage symptoms of Chronic Traumatic Encephalopathy (CTE) and recover from opioid addiction. The company offers a range of THC-free products, including tinctures, softgels, gummies, and topicals, designed to support recovery, reduce inflammation, and improve neurological health. Neuro XPF emphasizes bioavailability and third-party lab testing to ensure product purity and compliance with athletic drug testing standards. The brand is positioned as a natural alternative for pain management and performance enhancement in the sports industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neuro XPF.